Nordic Nanovector ASA(DE:8NN)
€0.38+-0.00 (+0.53%)
DE:8NN
Nordic Nanovector ASA financials statements
€0.38
At close:+-0.00 (+0.53%)
Nordic Nanovector ASA (8NN) Ratios
1 Followers
Nordic Nanovector ASA Ratios
DE:8NN's free cash flow for Q2 2026 was kr-89.40M. For the 2026 fiscal year, DE:8NN's free cash flow was decreased by kr-51.20M and operating cash flow was kr-38.20M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.57 | 5.68 | 10.20 | 2.46 | 1.92 |
| Quick Ratio | 4.50 | 5.68 | 10.20 | 2.46 | 1.92 |
| Cash Ratio | 4.13 | 5.39 | 9.29 | 2.18 | 1.82 |
| Solvency Ratio | -0.15 | -0.55 | -0.45 | -6.55 | -2.75 |
| Operating Cash Flow Ratio | -0.95 | -1.03 | -14.42 | -9.24 | -2.66 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr -53.20M | kr 52.70M | kr -13.56M | kr 63.30M | kr 134.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.47 | 0.00 | 0.00 | 0.00 | 0.02 |
| Debt-to-Equity Ratio | 0.72 | 0.00 | 0.00 | 0.00 | 0.04 |
| Debt-to-Capital Ratio | 0.42 | 0.00 | 0.00 | 0.00 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.55 | 1.23 | 1.22 | 1.72 | 2.11 |
| Debt Service Coverage Ratio | -74.17 | 3.96 | 0.00 | 0.00 | -1037.48 |
| Interest Coverage Ratio | -116.17 | -537.84 | 0.00 | 0.00 | -1081.19 |
| Debt to Market Cap | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Net Debt to EBITDA | -3.07 | 2952.18 | 6.05 | -8.60 | 0.63 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -17425.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -12200.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -17425.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -15575.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -14500.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -14500.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 93.10% | 98.99% | 477.72% | 0.00% | 100.26% |
| EBT Per EBIT | 89.38% | 80.89% | 75.76% | 0.00% | 98.33% |
| Return on Assets (ROA) | -8.19% | -10.19% | -8.03% | -283.86% | -148.75% |
| Return on Equity (ROE) | -12.72% | -12.52% | -9.77% | -487.52% | -314.06% |
| Return on Capital Employed (ROCE) | -10.48% | -13.46% | -2.25% | 0.00% | -308.75% |
| Return on Invested Capital (ROIC) | -9.58% | -13.31% | -2.25% | 0.00% | -297.45% |
| Return on Tangible Assets | -13.05% | -32.12% | -57.30% | -283.86% | -148.75% |
| Earnings Yield | -3.33% | -6.81% | -11.26% | -231.06% | -20.47% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.16 | 0.16 | 0.00 | 0.17 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 14600.00 | -2330.11 | -2319.02 | 0.00 | -2117.26 |
| Days of Sales Outstanding | 14600.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 2330.11 | 2319.02 | 0.00 | 2117.26 |
| Operating Cycle | 14600.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.13 | -0.10 | -0.37 | -3.55 | -4.26 |
| Free Cash Flow Per Share | -0.35 | -0.10 | -0.37 | -3.60 | -4.26 |
| Dividend Paid and CapEx Coverage Ratio | -0.57 | -237.00 | 0.00 | -72.69 | -1557.75 |
| Capital Expenditure Coverage Ratio | -0.57 | -237.00 | 0.00 | -72.69 | -1557.75 |
| Operating Cash Flow Coverage Ratio | -0.13 | -32.16 | 0.00 | -2572.82 | -73.25 |
| Operating Cash Flow to Sales Ratio | -103.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -6.57% | -3.84% | -27.16% | -307.87% | -18.72% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -30.88 | -14.61 | -8.88 | -0.43 | -4.89 |
| Price-to-Sales (P/S) Ratio | 4357.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 3.82 | 1.84 | 0.87 | 2.11 | 15.34 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.21 | -26.06 | -3.68 | -0.32 | -5.34 |
| Price-to-Operating Cash Flow Ratio | -42.00 | -26.17 | -3.68 | -0.33 | -5.34 |
| Price-to-Earnings Growth (PEG) Ratio | 5.56 | -0.03 | 0.09 | 0.01 | 0.23 |
| Enterprise Value Multiple | -38.79 | -11972.87 | -28.51 | 3.42 | -4.40 |
| Enterprise Value | 1.89B | 497.47M | 194.68M | 38.31M | 1.88B |
| EV to EBITDA | -38.79 | -11972.87 | -28.51 | 3.42 | -4.40 |
| EV to Sales | 4732.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -16.52 | -20.90 | -3.04 | -0.09 | -4.67 |
| EV to Operating Cash Flow | -45.61 | -20.99 | -3.04 | -0.09 | -4.67 |
| Tangible Book Value Per Share | 0.58 | 0.23 | -0.07 | 0.55 | 1.48 |
| Shareholders’ Equity Per Share | 1.37 | 1.43 | 1.56 | 0.55 | 1.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.07 | 0.01 | -0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.17 | -0.18 | -0.15 | -2.70 | -4.65 |
| Tax Burden | 0.93 | 0.99 | 4.78 | 0.00 | 1.00 |
| Interest Burden | 0.89 | 970.57 | 0.78 | 0.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 124.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.72 | 0.56 | 2.41 | 1.32 | 0.92 |
Currency in NOK
